Skip to main content

Noelia Díaz Troyano

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Noelia Díaz Troyano

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Projects

Detección precoz y estrategias preventivas del deterioro cognitivo en pacientes con epilepsia de reciente diagnóstico

IP: Elena Fonseca Hernandez
Collaborators: Manuel Toledo Argany, Laura Castillo Ribelles, Enric Bellido Castillo, Daniel Campos Fernández, Noelia Díaz Troyano, Samuel López Maza, Manuel Quintana Luque, Silvana Isabel Sarria Estrada
Funding agency: Instituto de Salud Carlos III
Funding: 196250
Reference: PI24/00862
Duration: 01/01/2025 - 31/12/2027

Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT)

IP: -
Collaborators: José Antonio Arranz Amo, Raquel Barquin Del Pino, Laura Conesa Milian, Clara Ramírez Serra, Yolanda Villena Ortiz, Joan López Hellin, Albert Blanco Grau, Roser Ferrer Costa, Joaquin Seras Franzoso, Diego Baranda Martínez-Abasca, Laura Castillo Ribelles, Clara Carnicer Cáceres, Marina Giralt Arnaiz, Ana Gomez Garcia, Simon Schwartz Navarro, Pablo Gabriel Medina, Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), Laura Castellote Bellés, Daniel Bravo Nieto, Luz María Cruz Carlos, Clara Sanz Gea, Alba Estela García Fernández, Maria del Pilar Reimundo Diaz-Fierros, Belen Garcia Prats, Noelia Díaz Troyano, JAUME VIMA BOFARULL, Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), Diana Fernandes de Rafael, Maria Francesca Cortese , Sandra Mancilla Zamora
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 01173
Duration: 01/01/2022 - 30/06/2025

Estudio de la quasiespecies del gen X en ARN circulante del virus de la hepatitis B (ARN-VHB): en búsqueda de nuevos factores pronósticos y dianas para terapia génica

IP: -
Collaborators: Noelia Díaz Troyano
Funding agency: Instituto de Salud Carlos III
Funding: 60000
Reference: INT19/00060
Duration: 01/06/2020 - 30/06/2021

Related news

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The new system, made of cellulose and chitosan, enables sustained release of docetaxel and has demonstrated antitumor activity in preclinical models of ovarian cancer and glioblastoma.

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

Related professionals

Verónica Pons Escoll

Verónica Pons Escoll

Main researcher
Transfusional Medicine
Read more
Patricia Guilabert Sanz

Patricia Guilabert Sanz

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Breogan Rodriguez Acevedo

Breogan Rodriguez Acevedo

Senior researcher
Clinical Neuroimmunology
Read more
Jacques Planas Morin

Jacques Planas Morin

Senior researcher
Biomedical Research in Urology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.